Soichiro Morinaga

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Medicine, Oncology, Chemotherapy +7

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Kohei Nakachi, Masafumi Ikeda, Masaru Konishi et al. · The Lancet · 2023 · 232 citations

Medicine, Oncology, Surgery +11

The clinical significance of SWI/SNF complex in pancreatic cancer

Masakatsu Numata, Soichiro Morinaga, Takuo Watanabe et al. · International Journal of Oncology · 2012 · 89 citations · Full text

Medicine, Cancer Biology, Oncology +14

The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease

Masakatsu Numata, Manabu Shiozawa, Takuo Watanabe et al. · World Journal of Surgical Oncology · 2012 · 83 citations · Full text

Medicine, Oncology, Surgery +14

Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer

Hiroshi Tamagawa, Takashi Oshima, Masakatsu Numata et al. · European Journal of Surgical Oncology · 2013 · 66 citations

Medicine, Molecular Biology, Oncology +17